Repositive closes £2.5m Series A fundraising
Repositive, a Cambridge company that boasts it has created the world’s largest portal for accessing human genomic research data, has closed a Series A funding round of £2.5 million.
The backers include lead investor Ananda Social Venture Fund, Force Over Mass Capital LLP and sees Amadeus Capital Partners and serial life science entrepreneur Dr Jonathan Milner increase their investment, having previously participated in seed funding. This latest success brings the total funds raised to date to £3.3m.
Fiona Nielsen (pictured), CEO of Repositive said: “This investment will allow Repositive to expand its commercial offering through the development of premium features for our fast growing community of platform users worldwide.
“Alongside this, we will invest further in expanding the range of data sources on our platform and developing further commercial products and services for the genomics R & D industry.
“I am delighted to welcome Ananda as lead investor and to see the continued support of Amadeus Capital and Jonathan Milner.”
Dr Milner said: “Repositive has made great progress in building its platform and the community it supports. With plans to commercialise the platform this year, Repositive is in a strong position to become a commercial and scientific global success.”